Biotechnology Investment Today to Host National Institutes of Health -NIH- and Pharma-Biotech ``Partnering'' Conference.Business Editors/Health/Medical Writers NIH "Not invented here." See digispeak. NIH - The United States National Institutes of Health. and Pharma-Biotech Partnering Conference SAN DIEGO--(BUSINESS WIRE)--July 3, 2003 Biotech CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Half-Day Workshop to Be Held July 17, 2003 in San Diego San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay. Biotechnology Investment Today, the scientific financial journal, today announced that it will host the NIH and Pharma-Biotech Partnering conference on July 17, 2003 in San Diego. The conference is part of the publication's BioBusiness Seminar and Investor Network Series and will be the first of its kind to provide pharma and biotech executives with the opportunity to discuss current strategies related to securing, fulfilling and capitalizing on collaborations with the NIH and pharmaceutical companies. The half-day seminar, open exclusively to biotechnology CEOs, will include prominent speakers from pharmaceutical companies such as Pfizer, the NIH and biotechnology industry experts. The agenda and registration information for the upcoming conference can be found on the Internet at www.investinbiotech.com. "Biotechnology Investment Today has quickly built a reputation for conceiving and organizing conferences with unique formats and workshops," said Stanley Yakatan, chairman, managing partner of Katan Associates International. "The upcoming partnering forum will bring together over 50 highly regarded biotechnology executives seeking critical information on making strategic management decisions and a networking opportunity to conduct real-time business." Focused on private equity and investment for biotech companies, the seminar will feature: -- Briefings from global investment leaders -- Peer level consultative briefings from world-class experts on strategy for CEOs -- Networking with leading VCs, Business Angels, Investment Banks, Big Pharma -- Funds and Institutional Investors Institutional Investor A non-bank person or organization that trades securities in large enough share quantities or dollar amounts that they qualify for preferential treatment and lower commissions. -- Parallel events in Maryland and New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of "Many industry and partnering conferences available to biotechnology executives today are set within a very structured format that can often limit critical discussion," said Dr. Morris Berrie, CEO, Biotechnology Investment Today. "Our goal with this conference is to provide a forum that facilitates a more lively and candid exchange of ideas, experiences, and successful strategies free of the traditional visual presentations, among a focused group of CEOs and consultants." Sponsors BIOCOM, Cooley Godward LLP LLP - Lower Layer Protocol , Ernst & Young, Euro RSCG Euro RSCG is an advertising agency network with global operations headquartered in New York. It is the main advertising agency network of the French communications group Havas, and is ranked 5th largest network according to Advertising Age Magazine, with over 233 offices in 75 Life NRP (Network Resource Planning) The planning, scheduling and control of a computer network. It includes documentation writing and network diagramming, analyses of traffic and congestion, analyses of application behavior and demand, procedures for failsafe and disaster , Invest Australia and Sanford Rose Associates About Biotechnology Investment Today Investinbiotech.com provides investors and biotechnology insiders with original and relevant information and data on all aspects of the biotechnology industry. Intelligent searching enables users to locate information about new scientific developments quickly and easily providing them with an invaluable aid in identifying new investment opportunities. Biotechnology Investment Today is our flagship magazine Flagship Magazine is an independent magazine for gamers [1]. Published in the UK, it started in 1983 for PBM players [2]. Since its hundredth issue in 2002, it has extended its coverage to include boardgames, role-playing games, web games and massively published quarterly and designed to provide insight into the industry from its own leaders and from government policy makers, market makers and analysts. It is our mission to serve the growing need for constantly updated information by institutional investors and venture capitalists eager to identify new and exciting Biotech companies. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion